{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:02:10Z","timestamp":1745748130568},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.genhosppsych.2008.03.007","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T08:58:20Z","timestamp":1216889900000},"page":"482-484","source":"Crossref","is-referenced-by-count":12,"title":["Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride"],"prefix":"10.1016","volume":"30","author":[{"given":"Petros","family":"Angelopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Markopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriakos","family":"Kyamidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Bobotas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2008.03.007_bib1","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4088\/JCP.v65n1219f","article-title":"Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome","volume":"65","author":"Atbasoglu","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1176\/appi.neuropsych.19.4.488","article-title":"Amisulpride-induced neuroleptic malignant syndrome","volume":"19","author":"Abay","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/WNF.0b013e3180cfe3a0","article-title":"Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy","volume":"30","author":"Peritogiannis","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2002-31518","article-title":"Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient","volume":"35","author":"Bottlender","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 8","key":"10.1016\/j.genhosppsych.2008.03.007_bib5","first-page":"9","article-title":"Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders","volume":"64","author":"Evins","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4088\/JCP.v65n0601","article-title":"Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels","volume":"65","author":"Stahl","year":"2004","journal-title":"J Clin Psychiatry."},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib7","first-page":"145","article-title":"Un neuroleptique majeur non phenothiazinique et non reserpinique, l' haloperidol, dans le traitement des psychoses","volume":"118","author":"Delay","year":"1960","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib8","unstructured":"Delay J., Deniker P., Drug-induced extrapyramidal syndromes. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology: diseases of the basal ganglia. Vol. 6. New York: Elsevier\/North Holland; 1968. p. 248\u201366."},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/ajp.155.8.1113","article-title":"Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique","volume":"155","author":"Hasan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1192\/bjp.151.5.689","article-title":"A possible variant of the neuroleptic malignant syndrome","volume":"151","author":"Sullivan","year":"1987","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1192\/bjp.157.3.437","article-title":"Carbamazepine and forme fruste neuroleptic malignant syndrome","volume":"157","author":"Dalkin","year":"1990","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00004583-199607000-00024","article-title":"Case study: neuroleptic malignant syndrome without pyrexia","volume":"35","author":"Hynes","year":"1996","journal-title":"J Am Child Adolesc Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/jnnp.69.2.277a","article-title":"Neuroleptic malignant syndrome without fever: a report of three cases","volume":"69","author":"Peiris","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib16","first-page":"435","article-title":"A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole","volume":"99","author":"Rodriguez","year":"2006","journal-title":"J Okla State Med Assoc"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib17","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","article-title":"Neuroleptic malignant syndrome: review and analysis of 115 cases","volume":"22","author":"Addonizio","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(88)90986-5","article-title":"Neuroleptic malignant syndrome after clozapine plus carbamazepine","volume":"2","author":"Muller","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0006-3223(98)00025-0","article-title":"Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome","volume":"44","author":"Nisijima","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1192\/bjp.154.1.102","article-title":"Concomitant treatment of neuroleptic malignant syndrome and psychosis","volume":"154","author":"Goldwasser","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib21","first-page":"381","article-title":"Carbamazepine in the treatment of neuroleptic malignant treatment","volume":"45","author":"Terao","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-3223(97)00450-2","article-title":"Carbamazepine in the treatment of neuroleptic malignant treatment","volume":"43","author":"Thomas","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1192\/bjp.164.2.269","article-title":"Neuroleptic malignant syndrome and carbamazepine?","volume":"164","author":"van Amelsvoort","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02244881","article-title":"Effect of switching carbamazepine to oxcarbamazepine on the plasma levels of neuroleptics. A case report","volume":"116","author":"Raitasuo","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1528-1167.2005.71104.x","article-title":"Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine","volume":"46","author":"Muscatello","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0924-977X(00)00079-1","article-title":"The antidepressive-like effect of the oxcarbazepine: possible role of dopaminergic neurotransmission","volume":"10","author":"Joca","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib27","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.45.10.1907","article-title":"Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters","volume":"45","author":"Waldmeier","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.genhosppsych.2008.03.007_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2125.2004.02129.x","article-title":"Severe overdosage with antiepileptic drug oxcarbazepine","volume":"58","author":"van Opstal","year":"2004","journal-title":"Br J Clin Pharmacol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834308000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834308000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T19:30:44Z","timestamp":1631561444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834308000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0163834308000431"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2008.03.007","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}